F C Hall
Overview
Explore the profile of F C Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hadjinicolaou A, Wu L, Fang B, Watson P, Hall F, Busch R
Clin Exp Immunol
. 2013 Jun;
174(1):73-88.
PMID: 23738744
The endothelial cell adhesion molecule, CD146, is expressed on ≈ 2% of normal circulating T cells, correlating with T cell activation, endothelial interactions and T helper type 17 (Th17) effector...
2.
Teir J, Koduri G, Meadows A, Griffin J, Kelsey C, Kola A, et al.
Rheumatology (Oxford)
. 2008 Jun;
47(8):1252-4.
PMID: 18573801
No abstract available.
3.
Hall F, Dalbeth N
Rheumatology (Oxford)
. 2005 Aug;
44(12):1473-82.
PMID: 16076883
Inflammatory rheumatic diseases are associated with a substantial increase in accelerated atherosclerosis, with complex interactions between traditional and disease-related risk factors. Therefore, cardiovascular risk reduction should be considered as integral...
4.
Loughry A, Fairchild S, Athanasou N, Edwards J, Hall F
Rheumatology (Oxford)
. 2005 Jan;
44(3):299-308.
PMID: 15637034
Objective: To investigate the effect of CD25+ or CTLA-4(+) cell depletion on the natural history of collagen-induced and spontaneous arthritis in male DBA1/J mice. Methods: Male DBA/1J mice were treated...
5.
Dalbeth N, Edwards J, Fairchild S, Callan M, Hall F
Rheumatology (Oxford)
. 2004 Sep;
44(1):24-31.
PMID: 15353612
Objectives: In addition to its vasoactive effects, angiotensin II has proinflammatory properties. Angiotensin-converting enzyme (ACE) inhibitors reduce the production of angiotensin II and could therefore act as anti-inflammatory agents. Here...
6.
Patil N, Hall F, Drover S, Spurrell D, Bos E, Cope A, et al.
J Immunol
. 2000 Dec;
166(1):33-41.
PMID: 11123274
It is hypothesized that autoimmune diseases manifest when tolerance to self-Ags fails. One possible mechanism to break tolerance is presentation of self-Ag in an altered form. Most Ags are presented...
7.
Sonderstrup G, Cope A, Patel S, Congia M, Hain N, Hall F, et al.
Immunol Rev
. 2000 Jan;
172:335-43.
PMID: 10631958
This review examines the field of current HLA class II transgenic mouse models and the individual approaches applied in production of these mice. The majority of these mice have been...
8.
Hall F, Cope A, Patel S, Sonderstrup G
Rheumatology (Oxford)
. 1999 Sep;
38(8):697-704.
PMID: 10501414
No abstract available.
9.
Parry S, Hall F, Olson J, Kamradt T, Sonderstrup G
Curr Opin Immunol
. 1999 Jan;
10(6):663-8.
PMID: 9914227
Antigen-specific B and T cell responses against myelin basic protein, as well as responses against beta-islet-cells or joint tissue, are commonly found both in patients with autoimmune disease and in...
10.
Maini M, Wedderburn L, Hall F, Wack A, Casorati G, Beverley P
Immunology
. 1998 Oct;
94(4):529-35.
PMID: 9767441
Oligoclonal or clonal T-cell expansions, presumed to be antigen driven, are frequently sought and followed for diagnostic and prognostic purposes, as well as to understand more about their natural history....